Analyst Expectations for 89bio's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish and somewhat bullish ratings for 89bio (NASDAQ:ETNB) in the last quarter. The average price target is $34.17, representing an upside from the current price of $8.35. This average is a 5.08% decrease from the previous average price target of $36.00.
October 11, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
89bio (NASDAQ:ETNB) has received bullish ratings from analysts, with an average price target of $34.17, indicating a potential upside.
The bullish ratings from analysts and the significant potential upside indicated by the average price target suggest a positive short-term impact on 89bio's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100